rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1999-6-3
|
pubmed:abstractText |
The use of platelet transfusions has risen considerably over the last few years, which leads to the collection and transfusion of a greater number of donor plateletpheresis units. Plateletpheresis activates platelets in platelet concentrates, which determines the degree of the storage lesion subsequently observed.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0041-1132
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
506-14
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10336001-Biotinylation,
pubmed-meshheading:10336001-Blood Preservation,
pubmed-meshheading:10336001-Cross-Over Studies,
pubmed-meshheading:10336001-Double-Blind Method,
pubmed-meshheading:10336001-Humans,
pubmed-meshheading:10336001-Infusions, Intravenous,
pubmed-meshheading:10336001-Male,
pubmed-meshheading:10336001-Nitric Oxide,
pubmed-meshheading:10336001-Nitroprusside,
pubmed-meshheading:10336001-Pilot Projects,
pubmed-meshheading:10336001-Platelet Activation,
pubmed-meshheading:10336001-Platelet Count,
pubmed-meshheading:10336001-Platelet Transfusion,
pubmed-meshheading:10336001-Plateletpheresis,
pubmed-meshheading:10336001-Reference Values
|
pubmed:year |
1999
|
pubmed:articleTitle |
Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans.
|
pubmed:affiliation |
Department of Clinical Pharmacology-TARGET, and Clinical Institute of Medical and Chemical Laboratory Diagnostics, Vienna University Hospital School of Medicine, Austria.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|